Acquisition by Gary Ellis of 716 shares of Inspire Medical subject to Rule 16b-3
| INSP Stock | USD 193.50 1.23 0.63% |
Slightly above 62% of Inspire Medical's investor base is looking to short. The analysis of the overall investor sentiment regarding Inspire Medical Systems suggests that many traders are alarmed. Inspire Medical's investing sentiment overview a quick insight into current market opportunities from investing in Inspire Medical Systems. Many technical investors use Inspire Medical Systems stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Inspire |
Filed transaction by Inspire Medical Systems Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Inspire Medical Fundamental Analysis
We analyze Inspire Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Inspire Medical is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Inspire Medical Systems Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inspire Medical stock to make a market-neutral strategy. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics with similar companies.
Peers
Inspire Medical Related Equities
| TMDX | TransMedics | 0.90 | ||||
| TNDM | Tandem Diabetes | 0.14 | ||||
| NARI | Inari Medical | 0.03 | ||||
| INMD | InMode | 0.35 | ||||
| GMED | Globus Medical | 0.43 | ||||
| PODD | Insulet | 0.59 | ||||
| PEN | Penumbra | 0.75 | ||||
| GKOS | Glaukos Corp | 0.83 | ||||
| CLPT | Clearpoint Neuro | 0.85 | ||||
| DXCM | DexCom | 0.90 | ||||
| OM | Outset Medical | 1.23 | ||||
| NVCR | Novocure | 3.88 |
Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.